The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 7 February 2005. doi:10.1084/jem2013iti3
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 3, 318-319
This Article
Right arrow Full Text (PDF, 790K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IN THIS ISSUE

DOKing TLR4 signals
Two adaptor proteins prevent cells from overreacting to bacterial lipopolysaccaride (LPS), report Shinohara et al. on page 333. Dok-1 and Dok-2 dampen intracellular signals from the LPS receptor, Toll-like receptor 4 (TLR4), which may help explain how cells mount a potent response to invading bacteria without also triggering destructive inflammatory responses.

Dok-1 and Dok-2 are adaptor proteins found in hematopoietic cells that are activated by tyrosine kinases in response to antigen and cytokine receptor signals. Once activated, they suppress intracellular signals by inhibiting the GTPase Ras, thereby keeping cellular activation and multiplication under control. The importance of this control is evident in mice lacking both proteins, which have been shown to develop leukemia.

Shinohara et al. now provide evidence that these proteins also inhibit LPS-induced TLR4 signals. Dok-1 and Dok-2 are tyrosine phosphorylated within 1 minute of LPS treatment, and cells lacking either protein displayed enhanced Erk activation in response to LPS. Mice lacking these proteins died from an unchecked production of the inflammatory cytokine TNF, a cause of endotoxic shock, when given a normally sublethal dose of LPS.

This is the first standby pathway described for TLR4 inhibition in macrophages; all other macrophage TLR4 regulators are inducible, suggesting that Dok-1 and Dok-2 may be primarily responsible for controlling the rapid process of primary endotoxic shock in these cells.{JEMiti_end}



Heather L. Van Epps

hvanepps{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
Hisaaki Shinohara, Akane Inoue, Noriko Toyama-Sorimachi, Yoshinori Nagai, Tomoharu Yasuda, Hiromi Suzuki, Reiko Horai, Yoichiro Iwakura, Tadashi Yamamoto, Hajime Karasuyama, Kensuke Miyake, and Yuji Yamanashi
J. Exp. Med. 2005 201: 333-339. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 790K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS